Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
EMHJ-Eastern Mediterranean Health Journal. 2002; 8 (4-5): 619-625
Dans Anglais | IMEMR | ID: emr-158103

Résumé

Intra-specimen and day-to-day variations of Fasciola egg counts in stools were investigated for 16 cases of established fascioliasis. For each case six Kato slides from a single stool sample were examined daily for 5 consecutive days. The results indicated the presence of significant intra-specimen variations in more than one-third of the examined series, while the inter-specimen variation was almost negligible. The sensitivity of the Kato-Katz test for diagnosing Fasciola infection with three Kato slides from the same specimen or on different days ranged from 96.0%-99.1%. The examination of three Kato smears from a single stool specimen, which is more feasible in field studies, would give an accurate diagnosis of fascioliasis. Used as such, the Kato-Katz technique is highly sensitive in the diagnosis of fascioliasis


Sujets)
Adulte , Animaux , Enfant , Humains , Fasciolase/diagnostic , Fèces/parasitologie , Numération des oeufs de parasites/méthodes , Prévalence , Sensibilité et spécificité , Facteurs temps
2.
EMHJ-Eastern Mediterranean Health Journal. 1999; 5 (5): 888-894
Dans Anglais | IMEMR | ID: emr-156679

Résumé

The efficacy of triclabendazole in the treatment of chronic Fasciola infection was assessed. A total of 134 asymptomatic cases of established Fasciola infection were treated: 68 individuals received a single dose of 10 mg/kg and 66 individuals received 2 doses of 10 mg/kg on 2 consecutive days. Cure was assessed 5 weeks after treatment and 79.4% of the first group and 93.9% of the second group were cured. The drug was well tolerated; no serious side-effects were noted. One patient developed biochemical cholestasis the third day after treatment, but her enzyme profiles returned to normal after 2 months. We conclude triclabendazole is a safe and potent fasciolicidic drug


Sujets)
Adolescent , Adulte , Enfant , Femelle , Humains , Mâle , Adulte d'âge moyen , Anthelminthiques/administration et posologie , Benzimidazoles/administration et posologie , Enfant d'âge préscolaire , Cholestase/enzymologie , Maladie chronique , Calendrier d'administration des médicaments , Maladies endémiques/prévention et contrôle , Tests de la fonction hépatique , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche